Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...

Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

Moderna MRNA kicked off 2025 with mixed first-quarter results. While its streamlining efforts improved bottom-line numbers, ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

Moderna (NASDAQ:MRNA) was in focus Thursday morning after the vaccine maker announced plans to expand its cost efficiency and ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

The UK’s drug representative body may expel the drug company Moderna over its handling of a case in which children were offered £1500 to participate in a clinical trial. The Prescription Medicines ...

チームは３０人を対象にした臨床試験で、米ファイザー社製のコロナワクチンを２回とも同じ腕に接種したグループと、別々の腕にしたグループの免疫反応を比較。ウイルスの働きを抑える中和抗体が増えるスピードが、同じ腕にしたグループの方が速く、２回目から１週間以内 ...

新型コロナ禍で世界中に普及したコロナワクチンは、昨年10月から65歳以上の高齢者を中心に定期接種が行われている。これまでは国の助成で自己負担額が抑えられていたが、厚労省は今月、今秋の接種から助成をやめる方針を固めた。そんな政府の対応はともかく、コロナ ...